adenosine kinase inhibitors (Metabasis)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameadenosine kinase inhibitors (Metabasis)
Drug Alias NameAK inhibitors (SICOR)tubercidin derivatives (Metabasis)AK inhibitors (Gensia)adenosine kinase inhibitors (SICOR)GP-4364 +[9] 
ClassificationSmall molecules
Mechanisms of ActionAdenosine kinase inhibitors
TargetsAdenosine kinase
Therapy Area/IndicationsInflammationEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSICOR Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetabasis Therapeutics IncSICOR SpaPfizer Japan Inc
Active IndicationsN/A
Inactive IndicationsInflammationEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A